The Nicotrol Inhaler (nicotine inhalation system) has been discontinued by Pfizer.
Your search for smoking cessation returned 21 results
Growing number of cigarette smokers are vaping to help them quit
Study reveals other smoking cessation aids are tied to more successful quits
Significantly fewer adverse reactions reported by those in the cytisine group versus the varenicline group.
N-nitroso-varenicline may be associated with an increased cancer risk based on data from closely related nitrosamine compounds.
To date, the Company has not received any reports of adverse events related to this recall.
However, early electronic cigarette quitters plus stable cigarette use was the most common trajectory in 41.6 percent of participants
Combining varenicline with nicotine patch, extending treatment from 12 to 24 weeks did not increase smoking cessation rates
Research has shown that menthol cigarettes are harder to quit than traditional tobacco products
Smoking bans, increased prices, and a lack of social acceptability are among reasons for the decline in traditional tobacco use.